Potential of heparin and nafamostat combination therapy for COVID‐19
Hidesaku Asakura, Haruhiko Ogawa
Topics & Concepts
MedicineCoagulopathyInternal medicineFibrinogenGastroenterologyDisseminated intravascular coagulationD-dimerCoronavirus disease 2019 (COVID-19)Anticoagulant therapyPneumoniaFibrinolysisCoagulationDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsLong-Term Effects of COVID-19